Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, $0.0001 par value · CUSIP: 76152G209
Event date: 2026-03-20
- Filing-level shares
- 363,280.00
- Percent of class
- 2.8%
- Parag SaxenaReported CIK 0001015823
Shares: 363,280.00 · Class: 2.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-012362
- Form type
- SCHEDULE 13D/A
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Mar 24, 2026
- Reporting period
- Mar 20, 2026
- Description
- Schedule 13D beneficial ownership